|
WO2021055846A1
|
|
Methods and compositions for treating myc-driven cancers
|
|
WO2021050547A1
|
|
Mitochondrial complex i inhibitors and methods of use
|
|
WO2021030606A1
|
|
Methods and devices for rare cell capture
|
|
WO2021022070A2
|
|
Prebiotic-induced anti-tumor immunity
|
|
WO2021021953A2
|
|
Dopamine receptor d1 agonists and methods of use
|
|
WO2021007208A1
|
|
Cxcr6 inhibitors and methods of use
|
|
WO2021003398A1
|
|
Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof
|
|
WO2020251952A2
|
|
Correcting protein misfolding in diabetes
|
|
WO2020247273A1
|
|
Machine-learning system for diagnosing disorders and diseases and determining drug responsiveness
|
|
WO2020247275A2
|
|
Uses of synthetic lethal partners for treatment of cancer
|
|
WO2020186218A2
|
|
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
|
|
WO2020186221A1
|
|
Biodegradable scaffold for hair growth and methods of use therefor
|
|
WO2020176461A2
|
|
Methods and compositions for treating neuroendocrine prostate cancer
|
|
WO2020160171A1
|
|
Topically formulated antibody compositions for reducing pathogen transmission and methods of using same
|
|
WO2020123543A2
|
|
Models and methods useful for the treatment of serrated colorectal cancer
|
|
WO2020051460A1
|
|
Methods of diagnosis and treatment of inflammatory bowel disease
|
|
AU2019319212A1
|
|
Binding molecules to tumor associated macrophages and methods of use
|
|
EP3810142A1
|
|
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of alzheimer's disease
|
|
WO2019217572A1
|
|
Role of pvt1 in the diagnosis and treatment of myc-driven cancer
|
|
WO2019183527A1
|
|
Oxidized bis(3-indolyl)methanes and uses thereof
|
